Shanghai Desano Chemical Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is EMTRICITABINE, with a corresponding US DMF Number 25617.
Remarkably, this DMF maintains an Active status since its submission on December 19, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 05, 2014, and payment made on February 07, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II